Cure My Disease

Don't miss your cure!

 Log in / Sign up

Extra blood tests could spot thyroid issues in preemies sooner

NCT ID NCT07425028

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study will check if doing two blood tests instead of one can better detect congenital hypothyroidism in premature babies born before 32 weeks. Researchers will follow 1,600 newborns in France, testing them within 15 days of birth and again at 2 years if needed. The goal is to see if European recommendations for repeat screening catch more cases than the current single-test approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to improved screening guidelines that catch congenital hypothyroidism earlier in premature babies, preventing developmental delays.
What could go wrong
This is an observational study, not a treatment trial. It only measures how many babies have the condition, so it won't directly improve outcomes. The results may not change current practice if the extra tests don't prove useful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HYPOTHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital hypothyroidism Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGENITAL HYPOTHYROIDISM

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chu de Lille

    Lille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.